MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Genetics"

  • 2019 International Congress

    Homozygous Huntington’s disease with two reduced penetrance alleles: A Case Report

    K. Grimm, C. Zühlke, C. Gerloff, S. Zittel (Hamburg, Germany)

    Objective: To clinically characterize a Huntington's disease patient with two reduced penetrance alleles. Background: Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder manifesting with…
  • 2019 International Congress

    Clinical and imaging characteristics of non-manifest LRRK2 and GBA carriers: The PPMI cohort

    A. Siderowf, T. Simuni, L. Uribe, C. Caspell-Garcia, H. Cho, C. Coffey, T. Foroud, B. Mollehauer, C. Tanner, K. Kieburtz, L. Chahine, D. Weintraub, K. Marek (Philadelphia, PA, USA)

    Objective: To examine baseline clinical and dopamine transporter (DAT) imaging characteristics in a cohort of non-manifest carriers (NMC) of GBA and LRRK2 compared to healthy…
  • 2019 International Congress

    Exploring the effects of intrastriatal AAV5-miHTT therapy on MRS signal and mutant huntingtin levels in the Q175FDN mouse model of HD

    B. Leavitt, A. Vallès, A. Stam, C. Brouwers, V. Fodale, A. Bresciani, A. Hill, A. Yung, B. Russell-Schulz, P. Kozlowski, A. Mackay, D. Ma, F. Beg, J. Higgins, S. van Deventer, M. Evers, P. Konstantinova (Vancouver, BC, Canada)

    Objective: To assess the effects of intrastriatal AAV5-miHTT therapy on MRS signal and mutant huntingtin levels in the Q175FDN mouse model of HD. Background: Huntingtin…
  • 2019 International Congress

    The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders

    M. Kurian, V. Leuzzi, K. Peall, R. Pons, R. Dale, E. de Grandis, S. Yilmaz, J. Cobben, R. Guerrini, E. Sheridan, P. Vieira, J. Uusimaa, P. Munot, F. Muntoni, M. Smith, S. Mohammed, E. Meyer, J. Ng, A. Papandreou, H. Baide, F. Danti, A. Macaya, J. Ortigoza, K. Gorman, B. Perez Duenas (Barcelona, Spain)

    Objective: To better delineate the genetic landscape and key clinical characteristics that define complex early onset monogenic hyperkinetic movement disorders (HMD). Background: Hyperkinetic movement disorders…
  • 2019 International Congress

    Prevalence of Huntington’s Disease in Sardinia, Italy

    A. Muroni, MR. Murru, T. Ercoli, V. Melas, E. Casaglia, M. Melis, E. Cocco, G. Defazio (Cagliari, Italy)

    Objective: We have performed a service-based epidemiological analysis extended to the population residing in Sardinia. The socio-cultural isolation of this large Mediterranean island makes genetic…
  • 2019 International Congress

    Huntington’s disease: A case review of Sub-Saharan Africans with diverse origins

    M. Muthinja, J. Hooker (Nairobi, Kenya)

    Objective: To characterise the Huntingtons disease phenotype in Sub-saharan Africans. Background: Huntington’s disease (HD) is a debilitating neurodegenerative illness that leads to diminished cognitive function,…
  • 2019 International Congress

    Intermediate CAG repeat length in the HTT gene and comorbidity – The SHAPE Study (Swedish-Huntingtin-Alleles-and-PhenotypE)

    M. Ghazarian, E. Stattin, J. Sundblom, V. Niemelä (Uppsala, Sweden)

    Objective: To 1) determine the distribution of CAG repeats of the Huntingtin gene in a Swedish general population sample, 2) explore the phenotype caused by…
  • 2019 International Congress

    Huntington’s Disease presenting as sporadic cerebellar ataxia

    GLF. Franklin, FAN. Nascimento, GMP. Pavanelli, SSM. Milano, HAT. Teive, NSL. Lima, SR. Raskin (Curitiba, Brazil)

    Objective: To describe a unique case of a woman who presented as a progressive cerebellar ataxia, with no family history of neurological diseases, that after…
  • 2019 International Congress

    Benign hereditary chorea: A Tunisian family case presentation

    M. Akkari, H. Ben Rhouma, H. Klaa, A. Rouissi, I. Kraoua, I. Turki (Tunis, Tunisia)

    Objective: To discuss clinical and genetic characteristics and therapeutic findings in a family with  Benign Hereditary Chorea(BFC). Background: Benign hereditary chorea (BHC) is a mild…
  • 2019 International Congress

    PNKP deficiency mimicking a benign hereditary chorea: the misleading presentation of a neurodegenerative disorder

    C. Caputi, M. Tolve, S. Galosi, M. Inghilleri, C. Carducci, A. Angeloni, V. Leuzzi (Roma, Italy)

    Objective: We report on a new case expanding the clinical presentation of PNKP deficiency Background: PNKP gene encodes for a kinase/phosphatase protein involved in DNA…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley